Domoxin

Domoxin
Clinical data
ATC code	None;
Identifiers
	IUPAC name 1-benzyl-1-(2,3-dihydro-1,4-benzodioxin-2-ylmethyl)hydrazine;
CAS Number	61-74-5;
PubChem CID	208853;
ChemSpider	180960;
UNII	5C0K1GQB2L;
ChEMBL	ChEMBL2105038;
Chemical and physical data
Formula	C16H18N2O2
Molar mass	270.332 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES O1c3c(OC(C1)CN(N)Cc2ccccc2)cccc3;
	InChI InChI=1S/C16H18N2O2/c17-18(10-13-6-2-1-3-7-13)11-14-12-19-15-8-4-5-9-16(15)20-14/h1-9,14H,10-12,17H2; Key:IXTXYSAWZICAPV-UHFFFAOYSA-N;

Domoxin (INN) is a hydrazine derivative monoamine oxidase inhibitor (MAOI) antidepressant which was never marketed.^[1]

References[edit]

This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.